MedCity News December 11, 2024
A new report by datma explores how companies can use federated data models to scale RWD.
The ability to collect data from electronic medical records, medical images, devices, diagnostics, wearables and apps means that more real world data (RWD) is available to be analyzed and derive insights from than ever before. At the same time, data management technologies, AI tools, and bioinformatics platforms are transforming data collection, processing and analysis for greater efficiency. The ability for institutions to share this data has implications for drug development, clinical trial recruitment, companion diagnostics and more.
Aggregated RWD is useful because it can address the diversity shortcomings of randomized clinical trials, which can take up to a year to recruit targeted patients. This...
Today's Sponsors
Today's Sponsor